Christine has served as Synthekine’s Vice President of Development Operations since October 2020. She has over 20 years research experience within the government, academic, public and private sectors. In her roles, Christine successfully led cross-functional product development teams in multiple therapeutic areas, built R&D operations organizations, and has been responsible for leading and overseeing trial strategy and execution from first-in-human trials to global Phase 3 studies for oncology companies such as BiPar Sciences and ARMO Biosciences. She earned a B.S. in organizational management and M.S. in Clinical Research Administration.